Express News Service
BENGALURU: Hospitals in Bengaluru could face a shortage of Covaxin doses in the coming days, throwing a spanner in the government’s Covid-19 immunization drive.Hyderabad-based Bharat Biotech has not been able to keep pace with demand for the vaccine, which has gone up in Bengaluru after after Chief Minister B S Yediyurappa and Health Minister Dr K Sudhakar took Covaxin last month.
“We started administering Covaxin around the end of March. Soon, 28 days will be over for the first set of beneficiaries. Unless supply increases, we won’t be able to cater to new beneficiaries as well as the ones who are to get their second shot. Whom should we prioritise?” said a doctor who works at a government hospital requesting anonymity.
LIVE
Mumbai News LIVE: CM Uddhav Thackeray seeks PM Modi s personal intervention to address Maharashtra s concerns
LIVE NOW
Mumbai News LIVE: CM Uddhav Thackeray seeks PM Modi s personal intervention to address Maharashtra s concerns
Maharashtra on Thursday reported 61,695 fresh coronavirus cases and took the total tally to 36,39,855. On the other hand, 349 people succumbed in the past 24 hours and the death toll reached 59,153. There are 6,20,060 active cases in the state.Meanwhile, with 8,217 new cases in Mumbai reported on Thursday, the total number of cases reached 5,53,159. However, 49 more Mumbaikars lost their life due to the COVID-19 virus.Maharashtra CM Uddhav Thackeray wrote a letter to Prime Minister Narendra Modi stressing the need for medical oxygen in the state for COVID treatment. Mumbai CP Hemant Nagrale also took stock of the COVID restriction in the city and urged people to stay safe at home.Stay tuned for all the latest updates here:
Adar Poonawalla tweeted an appeal to US President Joe Biden on Friday (File)
New Delhi:
Serum Institute CEO Adar Poonawalla on Friday urged US President Joe Biden to lift the embargo on export of raw materials needed for the production of the Covishield coronavirus vaccine in India.
Mr Poonawalla reminded Mr Biden the world had to truly unite to beat the pandemic, and that blocking access to raw materials would affect production of both the Covishield - which SII supplies to dozens of countries - and Novovax vaccines. Respected POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the US, I humbly request you to lift the embargo of raw material exports. so vaccine production can ramp up, he tweeted.
Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin. Outlook Web Bureau 2021-04-16T08:07:40+05:30 Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin outlookindia.com 2021-04-16T09:21:52+05:30
Also read
The centre has given its permission to the Mumbai-based Haffkine Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, an official said on Thursday.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister s office (CMO) said.
Express News Service
NEW DELHI: The Centre has now rushed to handhold Hyderabad-based Bharat Biotech in boosting the production of Covaxin, the country’s first and only indigenous Covid vaccine approved by the drug regulator, as a ferocious second wave of the pandemic has hit India hard.
After allowing Mumbai-based Haffkine Institute to produce Covaxin on a technology transfer basis following a plea by the Maharashtra government, the Union government has also decided to provide Rs 65 crore support to Bharat Biotech’s Bengaluru facility, said government sources.
Covaxin, apart from Covishield by the Serum Institute of India (SII), is the only available Covid vaccine in the country but its share has been fairly limited, only about 15% of about 11.75 crore doses administered, owing to its limited supply.